Vihang Jumle

India is a global supplier of generic drugs. Its export-oriented pharmaceutical industry is extremely profitable but encounters a number of challenges, from domestic demand to human resources. The Covid-19 pandemic has brought to light its dependence on imports from China of active pharmaceutical...

The Covid-19 pandemic has brought to light the specificities and some of the shortcomings of India’s healthcare infrastructure. This piece looks at the private healthcare system, an industry undergoing rapid development but which comes at a price that many can’t afford, and thus does not...

The Covid-19 crisis has tested the resilience of India's health system. Shortage of personnel and underfunded infrastructure are amongst the symptoms of India's ill public health system. In the first article of this new series on health issues in India, Christophe Jaffrelot, Senior Research Fellow...